Search research articles
Contact Us
Filters
Showing results (171-180 of 211) with videos related to
Page
of 22
Sort By:
Cellular and Molecular Gastroenterology and Hepatology
|
July 23, 2019
PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-Catenin<sup>Y654</sup>
Chenxi Gao, Guangming Chen, Dennis Han Zhang, et al.
Clinical Journal of Oncology Nursing
|
August 8, 2022
Burnout Among Oncology Nurses: The Effects of Providing a Primary Palliative Care Intervention Using CONNECT Protocol
Jessica B Cohen, Victoria L Reiser, Andrew D Althouse, et al.
Journal of Clinical Pharmacology
|
April 8, 2017
Parent-Metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT-888), a PARP Inhibitor, in Patients With BRCA 1/2-Mutated Cancer or PARP-Sensitive Tumor Types
Jing Niu, Christie Scheuerell, Shailly Mehrotra, et al.
Journal of Oncology Practice
|
December 5, 2013
Oncologist factors that influence referrals to subspecialty palliative care clinics
Yael Schenker, Megan Crowley-Matoka, Daniel Dohan, et al.
JCO Oncology Practice
|
November 12, 2021
Effects of an Oncology Nurse-Led, Primary Palliative Care Intervention (CONNECT) on Illness Expectations Among Patients With Advanced Cancer
Lauren E Sigler, Andrew D Althouse, Teresa H Thomas, et al.
The American Journal of Surgical Pathology
|
May 18, 2013
Signet ring cell colorectal carcinoma: a distinct subset of mucin-poor microsatellite-stable signet ring cell carcinoma associated with dismal prognosis
Douglas J Hartman, Marina N Nikiforova, Daniel T Chang, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
September 8, 2017
LC-MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasma
Julia Matsumoto, Brian F Kiesel, Robert A Parise, et al.
Cancer Chemotherapy and Pharmacology
|
September 19, 2020
Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker
Anand Joshi, Jianxia Guo, Julianne L Holleran, et al.
Clinical Pharmacology and Therapeutics
|
June 21, 2018
Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil Therapy
Jan H Beumer, Edward Chu, Carmen Allegra, et al.
Clinical Colorectal Cancer
|
August 24, 2011
A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer
Shivaani Kummar, M Sitki Copur, Michal Rose, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 211) with videos related to
Sort By:
Page
of 22
Cellular and Molecular Gastroenterology and Hepatology
|
July 23, 2019
PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-Catenin<sup>Y654</sup>
Chenxi Gao, Guangming Chen, Dennis Han Zhang, et al.
Clinical Journal of Oncology Nursing
|
August 8, 2022
Burnout Among Oncology Nurses: The Effects of Providing a Primary Palliative Care Intervention Using CONNECT Protocol
Jessica B Cohen, Victoria L Reiser, Andrew D Althouse, et al.
Journal of Clinical Pharmacology
|
April 8, 2017
Parent-Metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT-888), a PARP Inhibitor, in Patients With BRCA 1/2-Mutated Cancer or PARP-Sensitive Tumor Types
Jing Niu, Christie Scheuerell, Shailly Mehrotra, et al.
Journal of Oncology Practice
|
December 5, 2013
Oncologist factors that influence referrals to subspecialty palliative care clinics
Yael Schenker, Megan Crowley-Matoka, Daniel Dohan, et al.
JCO Oncology Practice
|
November 12, 2021
Effects of an Oncology Nurse-Led, Primary Palliative Care Intervention (CONNECT) on Illness Expectations Among Patients With Advanced Cancer
Lauren E Sigler, Andrew D Althouse, Teresa H Thomas, et al.
The American Journal of Surgical Pathology
|
May 18, 2013
Signet ring cell colorectal carcinoma: a distinct subset of mucin-poor microsatellite-stable signet ring cell carcinoma associated with dismal prognosis
Douglas J Hartman, Marina N Nikiforova, Daniel T Chang, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
September 8, 2017
LC-MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasma
Julia Matsumoto, Brian F Kiesel, Robert A Parise, et al.
Cancer Chemotherapy and Pharmacology
|
September 19, 2020
Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker
Anand Joshi, Jianxia Guo, Julianne L Holleran, et al.
Clinical Pharmacology and Therapeutics
|
June 21, 2018
Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil Therapy
Jan H Beumer, Edward Chu, Carmen Allegra, et al.
Clinical Colorectal Cancer
|
August 24, 2011
A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer
Shivaani Kummar, M Sitki Copur, Michal Rose, et al.
Page
of 22